U.S. drug distributors prevail in $2.5 billion West Virginia opioid case By Reuters

(Reuters) – McKesson Corp (NYSE:), AmerisourceBergen (NYSE:) Corp and Cardinal Health Inc (NYSE:) are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday.

The decision from U.S. District Judge David Faber came in a $2.5 billion case brought by the city of Huntington and Cabell County, which sought to hold the three largest U.S. drug distributors responsible for surging opioid prescriptions in their communities.